VivoSim Labs, INC. 8-KCurrent Reports (8-K / ad hoc)

Market for Equity / Stockholders

Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. On September 30, 2026, VivoSim Labs, Inc. (the “Company”) held its 2026 Annual Meeting of Stockholders (the “Annual Meeting”). At the Annual Meeting, the Company’s stockholders approved the amendment and restatement of the VivoSim Labs, Inc. Amended and Restated 2022 Equity Incentive Plan (the “Amended and Restated Plan”) to increase the number of shares reserved for issuance thereunder by 3,165,000 shares. The Amended and Restated Plan was previously approved by the Board of Directors of the Company (the “Board”), subject to stockholder approval. The Amended and Restated Plan became effective immediately upon stockholder approval at the Annual Meeting. A more complete summary of the terms of the Amended and Restated Plan is set forth in “Proposal 5: Approval of Amendment and Restatement of VivoSim Labs, Inc. Amended and Restated 2022 Equity Incentive Plan” in the Company’s definitive proxy statement filed with the Securities and Exchange Commission on August 21, 2026 (the “Proxy Statement”), which description and text are incorporated herein by reference. The foregoing description of the terms of the Amended and Restated Plan and the description thereof incorporated by reference from the Proxy Statement do not purport to be complete and are qualified in their entirety by reference to the full text of the Amended and Restated Plan, a copy of which is filed as Exhibit 10.1 hereto and is incorporated herein by reference. Item 5.07 Submission of Matters to a Vote of Security Holders. On September 30, 2026, Company held the Annual Meeting. Of the 16,586,495 shares of the Company’s common stock, par value $0.001 per share (the “Common Stock”), issued and outstanding as of the August 13, 2026 record date, 6,180,635 shares, or 37.26%, constituting a quorum, were represented at the Annual Meeting either virtually or by proxy. A description of each proposal voted upon at the Annual Meeting is included in the Proxy Statement. Set forth below is a brief description of each proposal voted upon at the Annual Meeting and the voting results with respect to each proposal. (1) Election of Directors . The Company’s stockholders elected Keith Murphy and Adam Stern as Class III directors, each to hold office until the 2029